Neuropharmacological, neuroprotective and amyloid precursor processing properties of selective MAO-B inhibitor antiparkinsonian drug, rasagiline.
about
Multi-Target Directed Donepezil-Like Ligands for Alzheimer's DiseaseOne for All? Hitting Multiple Alzheimer's Disease Targets with One DrugThe diverse functions of GAPDH: views from different subcellular compartmentsGlyceraldehyde-3-phosphate dehydrogenase-monoamine oxidase B-mediated cell death-induced by ethanol is prevented by rasagiline and 1-R-aminoindan.Multifunctional neuroprotective derivatives of rasagiline as anti-Alzheimer's disease drugsThe Neuroprotective Mechanism of Low-Frequency rTMS on Nigral Dopaminergic Neurons of Parkinson's Disease Model Mice.Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illnessShedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease.Why do we need multifunctional neuroprotective and neurorestorative drugs for Parkinson's and Alzheimer's disorders?GDNF therapy for Parkinson's disease.Dual-target-directed drugs that block monoamine oxidase B and adenosine A(2A) receptors for Parkinson's diseaseNeurotrophin strategies for neuroprotection: are they sufficient?Rasagiline and rapid symptomatic motor effect in Parkinson's disease: review of literature.Rasagiline protects against alpha-synuclein induced sensitivity to oxidative stress in dopaminergic cells.Comparative neuroprotective effects of rasagiline and aminoindan with selegiline on dexamethasone-induced brain cell apoptosis.Client perception of therapeutic factors in group psychotherapy and growth groups: an empirically-based hierarchical model.Toxicogenomic studies of human neural cells following exposure to organophosphorus chemical warfare nerve agent VX.Comparison of neuroprotective and neurorestorative capabilities of rasagiline and selegiline against lactacystin-induced nigrostriatal dopaminergic degeneration.Effect of gestational protein deficiency and excess on hepatic expression of genes related to cell cycle and proliferation in offspring from late gestation to finishing phase in pig.
P2860
Q26744105-20A187CE-F7FE-4406-9570-495B27FA36A2Q26747572-1F6A2ABD-D3FD-4294-AB78-2EECF2EC8C3FQ28291106-BB8DA041-DA7F-4A5D-8D3C-3A3CE19F07E2Q33821908-96E03CB4-7004-4686-90C0-DE8C0BBE8E02Q34911093-9DF434B2-ABD2-4DF5-8484-870C78BCC826Q35323480-45E9F741-3BFD-4455-B174-02420021F492Q35566604-2BC0D167-C11A-49D5-A907-3951427BA0A0Q36364388-9D71E59A-9E71-4436-97DD-F11A542340ECQ36919155-EED20764-77A0-4360-8742-3A31DC324E9BQ37203371-D820BE9A-741B-47B9-9DD7-F0244A5115BAQ37358676-54A737DA-04FF-41B6-A0FC-BB70F5472C15Q38194485-D269A93D-5ADA-4FBD-AB37-1A6A1FC29E0AQ38497529-7EFDD07A-165F-4E23-9372-8F8FB3A5809BQ39681299-822A70DB-1BFF-4332-9C22-F0181D9448E0Q42573791-4E6C9E7F-01A7-4A32-9574-776E8DA6C96BQ43521319-18242466-C9F7-4B16-A0D2-4625D053665BQ45902153-E9256A89-CAC7-4576-99F5-D32E8263F1F2Q46654865-856EFAF0-BF41-4C59-9C6A-34264F74D584Q51817507-6170C8B9-CE40-4595-9C33-CCE0872E748F
P2860
Neuropharmacological, neuroprotective and amyloid precursor processing properties of selective MAO-B inhibitor antiparkinsonian drug, rasagiline.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Neuropharmacological, neuropro ...... parkinsonian drug, rasagiline.
@ast
Neuropharmacological, neuropro ...... parkinsonian drug, rasagiline.
@en
type
label
Neuropharmacological, neuropro ...... parkinsonian drug, rasagiline.
@ast
Neuropharmacological, neuropro ...... parkinsonian drug, rasagiline.
@en
prefLabel
Neuropharmacological, neuropro ...... parkinsonian drug, rasagiline.
@ast
Neuropharmacological, neuropro ...... parkinsonian drug, rasagiline.
@en
P2093
P1433
P1476
Neuropharmacological, neuropro ...... parkinsonian drug, rasagiline.
@en
P2093
Makato Naoi
Moussa B H Youdim
Wakako Maruyama
P304
P356
10.1358/DOT.2005.41.6.893613
P577
2005-06-01T00:00:00Z